DiogenX’s EUR27.5 Million Serie A Fundraising

McDermott advised DiogenX in its fundraising.DiogenX, a biotechnology company specializing in the regeneration of beta cells that produce insulin for the treatment of diabetes, has announced…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Georgio Naffaa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here